Frankfurt - Delayed Quote • EUR
Biosynex SA (0DL.F)
At close: April 26 at 8:16 AM GMT+2
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
96,997.5430
196,586.5430
382,532.7520
153,895.3730
Cost of Revenue
47,356.2530
94,261.2530
176,118.7840
84,576.2110
Gross Profit
49,641.2900
102,325.2900
206,413.9680
69,319.1620
Operating Expense
77,948.8780
67,264.8780
65,295.5480
23,623.8250
Operating Income
-28,307.5880
35,060.4120
141,118.4200
45,695.3370
Net Non Operating Interest Income Expense
-146.0560
771.9440
94.9250
-224.6920
Pretax Income
-34,457.2690
29,802.7310
139,620.4860
44,370.0930
Tax Provision
-3,427.7330
8,571.2670
32,937.3510
12,149.8570
Net Income Common Stockholders
-34,326.8270
15,657.1730
104,004.4510
31,369.8250
Diluted NI Available to Com Stockholders
-34,326.8270
15,657.1730
104,004.4510
31,369.8250
Basic EPS
-3.40
1.53
10.08
3.52
Diluted EPS
-3.40
1.52
10.01
0.12
Basic Average Shares
10,116.0900
10,233.4460
10,317.9020
8,911.8820
Diluted Average Shares
10,148.9680
10,300.7720
10,390.0550
8,911.8820
Total Operating Income as Reported
-25,900.2400
38,882.7600
140,654.0590
45,734.5110
Total Expenses
125,305.1310
161,526.1310
241,414.3320
108,200.0360
Net Income from Continuing & Discontinued Operation
-34,326.8270
15,657.1730
104,004.4510
31,369.8250
Normalized Income
-28,920.4294
19,952.6775
105,221.5445
32,169.0130
Interest Income
1,199.6300
885.6300
57.8880
1.0660
Interest Expense
1,109.2410
501.2410
346.7230
224.3180
Net Interest Income
-146.0560
771.9440
94.9250
-224.6920
EBIT
-33,348.0280
30,303.9720
139,967.2090
44,594.4110
EBITDA
-1,175.5500
57,241.9450
146,579.7240
51,841.7780
Reconciled Cost of Revenue
47,356.2530
94,261.2530
176,118.7840
84,576.2110
Reconciled Depreciation
31,116.9380
26,937.9730
2,038.9900
7,247.3670
Net Income from Continuing Operation Net Minority Interest
-34,326.8270
15,657.1730
104,004.4510
31,369.8250
Total Unusual Items Excluding Goodwill
-6,003.6250
-6,029.6250
-1,592.8590
-1,100.5520
Total Unusual Items
-6,003.6250
-6,029.6250
-1,592.8590
-1,100.5520
Normalized EBITDA
4,828.0750
63,271.5700
148,172.5830
52,942.3300
Tax Rate for Calcs
0.0001
0.0003
0.0002
0.0003
Tax Effect of Unusual Items
-597.2274
-1,734.1205
-375.7655
-301.3640
12/31/2020 - 1/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade